Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and translational allergy"
DOI: 10.1002/clt2.12132
Abstract: BACKGROUND Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently avoided in mastocytosis, because of a potential increased risk for drug hypersensitivity reactions (DHRs) due to inhibition of cyclo-oxygenase (COX), subsequent depletion of prostaglandin E2 and release of… read more here.
Keywords: clinical laboratory; release; nsaids coxi; mediator ... See more keywords